WT
Wellcome Trust
Venture CapitalActiveThe Wellcome Trust is a British biomedical research charity.
102
Investments
10
Exits
38.8B
AUM
9.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Wellcome Trust.
Investment Thesis & Strategy
Wellcome Trust invests in various stages of biotech, healthcare, and non-profit companies, focusing on biomedical research and advancements.
Investment Activity
Deals per year over the last 14 years
1
20080
20091
20102
20110
20122
20130
20141
20152
20161
20170
20181
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 102 companies
B
Bit.bio
Biotech · Series B, 2021
H
Healx
Biotech · Series B, 2019
S
Synthace
Biotech · Series B, 2017
C
Congenica
Biotech · Series B, 2016
F
Freeline Therapeutics
Biotech · Series A, 2016
B
BenevolentAI
AI/ML · Growth, 2015
C
Crescendo Biologics
Biotech · Series A, 2013
I
Immunocore
Biotech · Growth, 2013
A
Autifony Therapeutics
Biotech · Series A, 2011
M
Mission Therapeutics
Biotech · Series A, 2011
A
Adaptimmune Therapeutics
Biotech · Growth, 2010
e
e-therapeutics
Biotech · Growth, 2008
Notable Exits
CompanyTypeYearValue / Acquirer
Oxford NanoporeIPO2021$3.6B
GW PharmaceuticalsAcquisition2021$7.2B
ImmunocoreIPO2021$2.8B
Autifony TherapeuticsAcquisition2020—
Achillion PharmaceuticalsAcquisition2019$930M
Adaptimmune TherapeuticsIPO2015—
Acacia PharmaIPO2015—
AffimedIPO2014—
AlgetaAcquisition2013$2.9B
CellzomeAcquisition2012—
Frequently Asked Questions
Wellcome Trust focuses on Series A, Series B, Series C+ stage investments.